Global Hydromorphone Market Growth 2023-2029

February 2023 | 111 pages | ID: G53F7561289CEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Hydromorphone, also known as dihydromorphinone, and sold under the brand name Dilaudid among others, is an opioid used to treat moderate to severe pain. Typically, long-term use is only recommended for pain due to cancer

LPI (LP Information)' newest research report, the “Hydromorphone Industry Forecast” looks at past sales and reviews total world Hydromorphone sales in 2022, providing a comprehensive analysis by region and market sector of projected Hydromorphone sales for 2023 through 2029. With Hydromorphone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hydromorphone industry.

This Insight Report provides a comprehensive analysis of the global Hydromorphone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hydromorphone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Hydromorphone market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hydromorphone and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hydromorphone.

The global Hydromorphone market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Hydromorphone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Hydromorphone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Hydromorphone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Hydromorphone players cover Purdue Pharma, Akorn, Barr Pharmaceuticals, Pfizer, Watson Laboratories, Mallinckrodt, Teva Pharmaceuticals, KV Pharmaceutical and Lannett, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Hydromorphone market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• Oral
• Injection

Segmentation by application

• Hospital
• Drug Store

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Purdue Pharma
• Akorn
• Barr Pharmaceuticals
• Pfizer
• Watson Laboratories
• Mallinckrodt
• Teva Pharmaceuticals
• KV Pharmaceutical
• Lannett
• Apotex
• Fresenius
• Johnson and Johnson
• Mundipharma
• Novartis
• Stada Arzneimittel
• Mylan

Key Questions Addressed in this Report

What is the 10-year outlook for the global Hydromorphone market?

What factors are driving Hydromorphone market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Hydromorphone market opportunities vary by end market size?

How does Hydromorphone break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Hydromorphone Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Hydromorphone by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Hydromorphone by Country/Region, 2018, 2022 & 2029
2.2 Hydromorphone Segment by Type
  2.2.1 Oral
  2.2.2 Injection
2.3 Hydromorphone Sales by Type
  2.3.1 Global Hydromorphone Sales Market Share by Type (2018-2023)
  2.3.2 Global Hydromorphone Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Hydromorphone Sale Price by Type (2018-2023)
2.4 Hydromorphone Segment by Application
  2.4.1 Hospital
  2.4.2 Drug Store
2.5 Hydromorphone Sales by Application
  2.5.1 Global Hydromorphone Sale Market Share by Application (2018-2023)
  2.5.2 Global Hydromorphone Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Hydromorphone Sale Price by Application (2018-2023)

3 GLOBAL HYDROMORPHONE BY COMPANY

3.1 Global Hydromorphone Breakdown Data by Company
  3.1.1 Global Hydromorphone Annual Sales by Company (2018-2023)
  3.1.2 Global Hydromorphone Sales Market Share by Company (2018-2023)
3.2 Global Hydromorphone Annual Revenue by Company (2018-2023)
  3.2.1 Global Hydromorphone Revenue by Company (2018-2023)
  3.2.2 Global Hydromorphone Revenue Market Share by Company (2018-2023)
3.3 Global Hydromorphone Sale Price by Company
3.4 Key Manufacturers Hydromorphone Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Hydromorphone Product Location Distribution
  3.4.2 Players Hydromorphone Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR HYDROMORPHONE BY GEOGRAPHIC REGION

4.1 World Historic Hydromorphone Market Size by Geographic Region (2018-2023)
  4.1.1 Global Hydromorphone Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Hydromorphone Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Hydromorphone Market Size by Country/Region (2018-2023)
  4.2.1 Global Hydromorphone Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Hydromorphone Annual Revenue by Country/Region (2018-2023)
4.3 Americas Hydromorphone Sales Growth
4.4 APAC Hydromorphone Sales Growth
4.5 Europe Hydromorphone Sales Growth
4.6 Middle East & Africa Hydromorphone Sales Growth

5 AMERICAS

5.1 Americas Hydromorphone Sales by Country
  5.1.1 Americas Hydromorphone Sales by Country (2018-2023)
  5.1.2 Americas Hydromorphone Revenue by Country (2018-2023)
5.2 Americas Hydromorphone Sales by Type
5.3 Americas Hydromorphone Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Hydromorphone Sales by Region
  6.1.1 APAC Hydromorphone Sales by Region (2018-2023)
  6.1.2 APAC Hydromorphone Revenue by Region (2018-2023)
6.2 APAC Hydromorphone Sales by Type
6.3 APAC Hydromorphone Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Hydromorphone by Country
  7.1.1 Europe Hydromorphone Sales by Country (2018-2023)
  7.1.2 Europe Hydromorphone Revenue by Country (2018-2023)
7.2 Europe Hydromorphone Sales by Type
7.3 Europe Hydromorphone Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Hydromorphone by Country
  8.1.1 Middle East & Africa Hydromorphone Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Hydromorphone Revenue by Country (2018-2023)
8.2 Middle East & Africa Hydromorphone Sales by Type
8.3 Middle East & Africa Hydromorphone Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hydromorphone
10.3 Manufacturing Process Analysis of Hydromorphone
10.4 Industry Chain Structure of Hydromorphone

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Hydromorphone Distributors
11.3 Hydromorphone Customer

12 WORLD FORECAST REVIEW FOR HYDROMORPHONE BY GEOGRAPHIC REGION

12.1 Global Hydromorphone Market Size Forecast by Region
  12.1.1 Global Hydromorphone Forecast by Region (2024-2029)
  12.1.2 Global Hydromorphone Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hydromorphone Forecast by Type
12.7 Global Hydromorphone Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Purdue Pharma
  13.1.1 Purdue Pharma Company Information
  13.1.2 Purdue Pharma Hydromorphone Product Portfolios and Specifications
  13.1.3 Purdue Pharma Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Purdue Pharma Main Business Overview
  13.1.5 Purdue Pharma Latest Developments
13.2 Akorn
  13.2.1 Akorn Company Information
  13.2.2 Akorn Hydromorphone Product Portfolios and Specifications
  13.2.3 Akorn Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Akorn Main Business Overview
  13.2.5 Akorn Latest Developments
13.3 Barr Pharmaceuticals
  13.3.1 Barr Pharmaceuticals Company Information
  13.3.2 Barr Pharmaceuticals Hydromorphone Product Portfolios and Specifications
  13.3.3 Barr Pharmaceuticals Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Barr Pharmaceuticals Main Business Overview
  13.3.5 Barr Pharmaceuticals Latest Developments
13.4 Pfizer
  13.4.1 Pfizer Company Information
  13.4.2 Pfizer Hydromorphone Product Portfolios and Specifications
  13.4.3 Pfizer Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Pfizer Main Business Overview
  13.4.5 Pfizer Latest Developments
13.5 Watson Laboratories
  13.5.1 Watson Laboratories Company Information
  13.5.2 Watson Laboratories Hydromorphone Product Portfolios and Specifications
  13.5.3 Watson Laboratories Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Watson Laboratories Main Business Overview
  13.5.5 Watson Laboratories Latest Developments
13.6 Mallinckrodt
  13.6.1 Mallinckrodt Company Information
  13.6.2 Mallinckrodt Hydromorphone Product Portfolios and Specifications
  13.6.3 Mallinckrodt Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Mallinckrodt Main Business Overview
  13.6.5 Mallinckrodt Latest Developments
13.7 Teva Pharmaceuticals
  13.7.1 Teva Pharmaceuticals Company Information
  13.7.2 Teva Pharmaceuticals Hydromorphone Product Portfolios and Specifications
  13.7.3 Teva Pharmaceuticals Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Teva Pharmaceuticals Main Business Overview
  13.7.5 Teva Pharmaceuticals Latest Developments
13.8 KV Pharmaceutical
  13.8.1 KV Pharmaceutical Company Information
  13.8.2 KV Pharmaceutical Hydromorphone Product Portfolios and Specifications
  13.8.3 KV Pharmaceutical Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 KV Pharmaceutical Main Business Overview
  13.8.5 KV Pharmaceutical Latest Developments
13.9 Lannett
  13.9.1 Lannett Company Information
  13.9.2 Lannett Hydromorphone Product Portfolios and Specifications
  13.9.3 Lannett Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Lannett Main Business Overview
  13.9.5 Lannett Latest Developments
13.10 Apotex
  13.10.1 Apotex Company Information
  13.10.2 Apotex Hydromorphone Product Portfolios and Specifications
  13.10.3 Apotex Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Apotex Main Business Overview
  13.10.5 Apotex Latest Developments
13.11 Fresenius
  13.11.1 Fresenius Company Information
  13.11.2 Fresenius Hydromorphone Product Portfolios and Specifications
  13.11.3 Fresenius Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 Fresenius Main Business Overview
  13.11.5 Fresenius Latest Developments
13.12 Johnson and Johnson
  13.12.1 Johnson and Johnson Company Information
  13.12.2 Johnson and Johnson Hydromorphone Product Portfolios and Specifications
  13.12.3 Johnson and Johnson Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.12.4 Johnson and Johnson Main Business Overview
  13.12.5 Johnson and Johnson Latest Developments
13.13 Mundipharma
  13.13.1 Mundipharma Company Information
  13.13.2 Mundipharma Hydromorphone Product Portfolios and Specifications
  13.13.3 Mundipharma Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.13.4 Mundipharma Main Business Overview
  13.13.5 Mundipharma Latest Developments
13.14 Novartis
  13.14.1 Novartis Company Information
  13.14.2 Novartis Hydromorphone Product Portfolios and Specifications
  13.14.3 Novartis Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.14.4 Novartis Main Business Overview
  13.14.5 Novartis Latest Developments
13.15 Stada Arzneimittel
  13.15.1 Stada Arzneimittel Company Information
  13.15.2 Stada Arzneimittel Hydromorphone Product Portfolios and Specifications
  13.15.3 Stada Arzneimittel Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.15.4 Stada Arzneimittel Main Business Overview
  13.15.5 Stada Arzneimittel Latest Developments
13.16 Mylan
  13.16.1 Mylan Company Information
  13.16.2 Mylan Hydromorphone Product Portfolios and Specifications
  13.16.3 Mylan Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2023)
  13.16.4 Mylan Main Business Overview
  13.16.5 Mylan Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Hydromorphone Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Hydromorphone Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injection
Table 5. Global Hydromorphone Sales by Type (2018-2023) & (K Units)
Table 6. Global Hydromorphone Sales Market Share by Type (2018-2023)
Table 7. Global Hydromorphone Revenue by Type (2018-2023) & ($ million)
Table 8. Global Hydromorphone Revenue Market Share by Type (2018-2023)
Table 9. Global Hydromorphone Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Hydromorphone Sales by Application (2018-2023) & (K Units)
Table 11. Global Hydromorphone Sales Market Share by Application (2018-2023)
Table 12. Global Hydromorphone Revenue by Application (2018-2023)
Table 13. Global Hydromorphone Revenue Market Share by Application (2018-2023)
Table 14. Global Hydromorphone Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Hydromorphone Sales by Company (2018-2023) & (K Units)
Table 16. Global Hydromorphone Sales Market Share by Company (2018-2023)
Table 17. Global Hydromorphone Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Hydromorphone Revenue Market Share by Company (2018-2023)
Table 19. Global Hydromorphone Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Hydromorphone Producing Area Distribution and Sales Area
Table 21. Players Hydromorphone Products Offered
Table 22. Hydromorphone Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Hydromorphone Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Hydromorphone Sales Market Share Geographic Region (2018-2023)
Table 27. Global Hydromorphone Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Hydromorphone Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Hydromorphone Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Hydromorphone Sales Market Share by Country/Region (2018-2023)
Table 31. Global Hydromorphone Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Hydromorphone Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Hydromorphone Sales by Country (2018-2023) & (K Units)
Table 34. Americas Hydromorphone Sales Market Share by Country (2018-2023)
Table 35. Americas Hydromorphone Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Hydromorphone Revenue Market Share by Country (2018-2023)
Table 37. Americas Hydromorphone Sales by Type (2018-2023) & (K Units)
Table 38. Americas Hydromorphone Sales by Application (2018-2023) & (K Units)
Table 39. APAC Hydromorphone Sales by Region (2018-2023) & (K Units)
Table 40. APAC Hydromorphone Sales Market Share by Region (2018-2023)
Table 41. APAC Hydromorphone Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Hydromorphone Revenue Market Share by Region (2018-2023)
Table 43. APAC Hydromorphone Sales by Type (2018-2023) & (K Units)
Table 44. APAC Hydromorphone Sales by Application (2018-2023) & (K Units)
Table 45. Europe Hydromorphone Sales by Country (2018-2023) & (K Units)
Table 46. Europe Hydromorphone Sales Market Share by Country (2018-2023)
Table 47. Europe Hydromorphone Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Hydromorphone Revenue Market Share by Country (2018-2023)
Table 49. Europe Hydromorphone Sales by Type (2018-2023) & (K Units)
Table 50. Europe Hydromorphone Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Hydromorphone Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Hydromorphone Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Hydromorphone Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Hydromorphone Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Hydromorphone Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Hydromorphone Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Hydromorphone
Table 58. Key Market Challenges & Risks of Hydromorphone
Table 59. Key Industry Trends of Hydromorphone
Table 60. Hydromorphone Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Hydromorphone Distributors List
Table 63. Hydromorphone Customer List
Table 64. Global Hydromorphone Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Hydromorphone Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Hydromorphone Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Hydromorphone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Hydromorphone Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Hydromorphone Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Hydromorphone Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Hydromorphone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Hydromorphone Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Hydromorphone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Hydromorphone Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Hydromorphone Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Hydromorphone Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Hydromorphone Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Purdue Pharma Basic Information, Hydromorphone Manufacturing Base, Sales Area and Its Competitors
Table 79. Purdue Pharma Hydromorphone Product Portfolios and Specifications
Table 80. Purdue Pharma Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Purdue Pharma Main Business
Table 82. Purdue Pharma Latest Developments
Table 83. Akorn Basic Information, Hydromorphone Manufacturing Base, Sales Area and Its Competitors
Table 84. Akorn Hydromorphone Product Portfolios and Specifications
Table 85. Akorn Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Akorn Main Business
Table 87. Akorn Latest Developments
Table 88. Barr Pharmaceuticals Basic Information, Hydromorphone Manufacturing Base, Sales Area and Its Competitors
Table 89. Barr Pharmaceuticals Hydromorphone Product Portfolios and Specifications
Table 90. Barr Pharmaceuticals Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Barr Pharmaceuticals Main Business
Table 92. Barr Pharmaceuticals Latest Developments
Table 93. Pfizer Basic Information, Hydromorphone Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Hydromorphone Product Portfolios and Specifications
Table 95. Pfizer Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Pfizer Main Business
Table 97. Pfizer Latest Developments
Table 98. Watson Laboratories Basic Information, Hydromorphone Manufacturing Base, Sales Area and Its Competitors
Table 99. Watson Laboratories Hydromorphone Product Portfolios and Specifications
Table 100. Watson Laboratories Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Watson Laboratories Main Business
Table 102. Watson Laboratories Latest Developments
Table 103. Mallinckrodt Basic Information, Hydromorphone Manufacturing Base, Sales Area and Its Competitors
Table 104. Mallinckrodt Hydromorphone Product Portfolios and Specifications
Table 105. Mallinckrodt Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Mallinckrodt Main Business
Table 107. Mallinckrodt Latest Developments
Table 108. Teva Pharmaceuticals Basic Information, Hydromorphone Manufacturing Base, Sales Area and Its Competitors
Table 109. Teva Pharmaceuticals Hydromorphone Product Portfolios and Specifications
Table 110. Teva Pharmaceuticals Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Teva Pharmaceuticals Main Business
Table 112. Teva Pharmaceuticals Latest Developments
Table 113. KV Pharmaceutical Basic Information, Hydromorphone Manufacturing Base, Sales Area and Its Competitors
Table 114. KV Pharmaceutical Hydromorphone Product Portfolios and Specifications
Table 115. KV Pharmaceutical Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. KV Pharmaceutical Main Business
Table 117. KV Pharmaceutical Latest Developments
Table 118. Lannett Basic Information, Hydromorphone Manufacturing Base, Sales Area and Its Competitors
Table 119. Lannett Hydromorphone Product Portfolios and Specifications
Table 120. Lannett Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Lannett Main Business
Table 122. Lannett Latest Developments
Table 123. Apotex Basic Information, Hydromorphone Manufacturing Base, Sales Area and Its Competitors
Table 124. Apotex Hydromorphone Product Portfolios and Specifications
Table 125. Apotex Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Apotex Main Business
Table 127. Apotex Latest Developments
Table 128. Fresenius Basic Information, Hydromorphone Manufacturing Base, Sales Area and Its Competitors
Table 129. Fresenius Hydromorphone Product Portfolios and Specifications
Table 130. Fresenius Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Fresenius Main Business
Table 132. Fresenius Latest Developments
Table 133. Johnson and Johnson Basic Information, Hydromorphone Manufacturing Base, Sales Area and Its Competitors
Table 134. Johnson and Johnson Hydromorphone Product Portfolios and Specifications
Table 135. Johnson and Johnson Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Johnson and Johnson Main Business
Table 137. Johnson and Johnson Latest Developments
Table 138. Mundipharma Basic Information, Hydromorphone Manufacturing Base, Sales Area and Its Competitors
Table 139. Mundipharma Hydromorphone Product Portfolios and Specifications
Table 140. Mundipharma Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Mundipharma Main Business
Table 142. Mundipharma Latest Developments
Table 143. Novartis Basic Information, Hydromorphone Manufacturing Base, Sales Area and Its Competitors
Table 144. Novartis Hydromorphone Product Portfolios and Specifications
Table 145. Novartis Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Novartis Main Business
Table 147. Novartis Latest Developments
Table 148. Stada Arzneimittel Basic Information, Hydromorphone Manufacturing Base, Sales Area and Its Competitors
Table 149. Stada Arzneimittel Hydromorphone Product Portfolios and Specifications
Table 150. Stada Arzneimittel Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Stada Arzneimittel Main Business
Table 152. Stada Arzneimittel Latest Developments
Table 153. Mylan Basic Information, Hydromorphone Manufacturing Base, Sales Area and Its Competitors
Table 154. Mylan Hydromorphone Product Portfolios and Specifications
Table 155. Mylan Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Mylan Main Business
Table 157. Mylan Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Hydromorphone
Figure 2. Hydromorphone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hydromorphone Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Hydromorphone Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Hydromorphone Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of Injection
Figure 11. Global Hydromorphone Sales Market Share by Type in 2022
Figure 12. Global Hydromorphone Revenue Market Share by Type (2018-2023)
Figure 13. Hydromorphone Consumed in Hospital
Figure 14. Global Hydromorphone Market: Hospital (2018-2023) & (K Units)
Figure 15. Hydromorphone Consumed in Drug Store
Figure 16. Global Hydromorphone Market: Drug Store (2018-2023) & (K Units)
Figure 17. Global Hydromorphone Sales Market Share by Application (2022)
Figure 18. Global Hydromorphone Revenue Market Share by Application in 2022
Figure 19. Hydromorphone Sales Market by Company in 2022 (K Units)
Figure 20. Global Hydromorphone Sales Market Share by Company in 2022
Figure 21. Hydromorphone Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Hydromorphone Revenue Market Share by Company in 2022
Figure 23. Global Hydromorphone Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Hydromorphone Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Hydromorphone Sales 2018-2023 (K Units)
Figure 26. Americas Hydromorphone Revenue 2018-2023 ($ Millions)
Figure 27. APAC Hydromorphone Sales 2018-2023 (K Units)
Figure 28. APAC Hydromorphone Revenue 2018-2023 ($ Millions)
Figure 29. Europe Hydromorphone Sales 2018-2023 (K Units)
Figure 30. Europe Hydromorphone Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Hydromorphone Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Hydromorphone Revenue 2018-2023 ($ Millions)
Figure 33. Americas Hydromorphone Sales Market Share by Country in 2022
Figure 34. Americas Hydromorphone Revenue Market Share by Country in 2022
Figure 35. Americas Hydromorphone Sales Market Share by Type (2018-2023)
Figure 36. Americas Hydromorphone Sales Market Share by Application (2018-2023)
Figure 37. United States Hydromorphone Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Hydromorphone Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Hydromorphone Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Hydromorphone Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Hydromorphone Sales Market Share by Region in 2022
Figure 42. APAC Hydromorphone Revenue Market Share by Regions in 2022
Figure 43. APAC Hydromorphone Sales Market Share by Type (2018-2023)
Figure 44. APAC Hydromorphone Sales Market Share by Application (2018-2023)
Figure 45. China Hydromorphone Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Hydromorphone Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Hydromorphone Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Hydromorphone Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Hydromorphone Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Hydromorphone Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Hydromorphone Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Hydromorphone Sales Market Share by Country in 2022
Figure 53. Europe Hydromorphone Revenue Market Share by Country in 2022
Figure 54. Europe Hydromorphone Sales Market Share by Type (2018-2023)
Figure 55. Europe Hydromorphone Sales Market Share by Application (2018-2023)
Figure 56. Germany Hydromorphone Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Hydromorphone Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Hydromorphone Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Hydromorphone Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Hydromorphone Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Hydromorphone Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Hydromorphone Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Hydromorphone Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Hydromorphone Sales Market Share by Application (2018-2023)
Figure 65. Egypt Hydromorphone Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Hydromorphone Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Hydromorphone Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Hydromorphone Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Hydromorphone Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Hydromorphone in 2022
Figure 71. Manufacturing Process Analysis of Hydromorphone
Figure 72. Industry Chain Structure of Hydromorphone
Figure 73. Channels of Distribution
Figure 74. Global Hydromorphone Sales Market Forecast by Region (2024-2029)
Figure 75. Global Hydromorphone Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Hydromorphone Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Hydromorphone Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Hydromorphone Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Hydromorphone Revenue Market Share Forecast by Application (2024-2029)